38554-25-5 (6,9,11-三羟基-9-(2-羟基乙酰基)-4-甲氧基-8,10-二氢-7H-并四苯-5,12-二酮,7-Deoxy Doxorubicin Aglycone (> 75%))

6,9,11-三羟基-9-(2-羟基乙酰基)-4-甲氧基-8,10-二氢-7H-并四苯-5,12-二酮;

7-deoxydoxorubicinone;7-Deoxy Doxorubicin Aglycone;Doxorubicin 7-deoxyaglycone;NSC-270536;Q27291737;Adriamycin 7-deoxyaglycone;7-Deoxy Doxorubicin Aglycone (> 75%);(R)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione;NSC 270536;(9R)-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (R)-;5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8R)-;8-Glycoloyl-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydro-5,12-naphthacenedione #;7-Deoxyepirubicin Aglycone;UNII-VB2YU5128G;7-Deoxydoxorubicin aglycone;7-Deoxyadriamycinone;(8R)-7,8,9,10-Tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione;38554-25-5;CHEMBL3508144;SCHEMBL12228502;7-Deoxyadriamycin aglycone;VB2YU5128G;G91389;

QHGFPRZWWKUHKF-OAQYLSRUSA-N

1S/C21H18O8/c1-29-12-4-2-3-10-14(12)20(27)16-15(18(10)25)19(26)11-7-21(28,13(23)8-22)6-5-9(11)17(16)24/h2-4,22,24,26,28H,5-8H2,1H3/t21-/m1/s1

O[C@@]1(C(CO)=O)CC2C(=C3C(C4C=CC=C(C=4C(C3=C(C=2CC1)O)=O)OC)=O)O